Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
J

Trastuzumab Deruxtecan in HER2+ MBC Efficacy Analysis

By Cleveland Clinic Taussig Cancer Institute FEATURING Jame Abraham
By Cleveland Clinic Taussig Cancer Institute FEATURING Jame Abraham
468 views
October 5, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
ASCO 2020 Highlights
09:21

Trastuzumab Deruxtecan in HER2+ MBC Efficacy Analysis

Cleveland Clinic Taussig Cancer Institute

J. Abraham

468 views
11:48

2020 ASCO Update on Locally Advanced Rectal Cancer: Can Total Neoadj…

Cleveland Clinic Taussig Cancer Institute

S. Kamath

747 views